GL1X · GenesisL1 explorer

Research workbench

P14-fluorescein-N135Q-S380C-antithrombin-III

Analyse P14-fluorescein-N135Q-S380C-antithrombin-III in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1DZH
Type
protein
Length
825 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antithrombin-III
UniProt
P01008
Ligands
NAG, BMA
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
IAntithrombin-IIIprotein41831% helix, 30% strandP01008
LAntithrombin-IIIprotein40729% helix, 31% strandP01008

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 9 copies · chains I, L
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • GOL · Glycerol · additive · 2 copies · chains I, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16570.740.8172empty
2700.630.9119GOL
31350.620.8525GOL
42480.540.7635empty
5600.370.7916empty

Interfaces

1 interface between chains.

  • I–L · 928 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 6 glycan, 1 modified (disulfide, N-glycosylation, nonstandard).

Compared structures

  • 1DZH · P14-fluorescein-N135Q-S380C-antithrombin-III · the same entry in another collection · chain I against I, TM-score 1.00
  • P01008 · AlphaFold monomer V2.0 prediction for antithrombin-III (P01008) · a predicted model of the same protein · chain I against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.